HK StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

TRANSTHERA-B

75.800

+12.70020.13%

Volume:2.66M

Turnover:195.69M

Market Cap:30.09B

PE:-96.29

High:78.900

Open:65.150

Low:63.650

Close:63.100

52wk High:78.900

52wk Low:20.200

Shares:397.00M

HK Float Shares:301.67M

Volume Ratio:16.91

T/O Rate:0.88%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-0.787

ROE:-65.31%

ROA:-35.56%

PB:47.25

PE(LYR):-96.29

PS:- -

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

HK Movers | Transthera-B, DualityBio-B Shares Surged About 16% After Being Added to the List of Securities for Southbound Trading

Tiger Newspress

TRANSTHERA-B Surges Nearly 11% in Early Trading to New Listing High as Company Joins Stock Connect

TRANSTHERA-B (02617): Phase II Clinical Trial of Tinengotinib Combined with AKESO's Kantani® (Cadonilimab, PD-1/CTLA-4) / Ivonesca® (Ivonescimab, PD-1/VEGF) Completes First Patient Dosing

TransThera Sciences Announces First Patient Dosed in Phase II Clinical Trial for Advanced Liver Cancer Treatment

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/02617"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02617","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02617\",,,,,undefined,":{"symbol":"02617","market":"HK","secType":"STK","nameCN":"TRANSTHERA-B","latestPrice":75.8,"timestamp":1757318886312,"preClose":63.1,"halted":0,"volume":2658720,"delay":0,"floatShares":301666673,"shares":397000000,"eps":-0.7871997137335578,"marketStatus":"Not Yet Opened","change":12.7,"latestTime":"09-08 16:08:06","open":65.15,"high":78.9,"low":63.65,"amount":195686605,"amplitude":0.24168,"askPrice":75.8,"askSize":3500,"bidPrice":75.05,"bidSize":500,"shortable":0,"etf":0,"ttmEps":-1.1349883620721901,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1757381400000},"marketStatusCode":0,"adr":0,"listingDate":1750608000000,"exchange":"SEHK","adjPreClose":63.1,"openAndCloseTimeList":[[1757295000000,1757304000000],[1757307600000,1757318400000]],"volumeRatio":16.90910479484227,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02617\",,,,,undefined,":{"symbol":"02617","floatShares":301666673,"roa":"-35.56%","roe":"-65.31%","lyrEps":-0.7872,"volumeRatio":16.90910479484227,"shares":397000000,"dividePrice":0,"high":78.9,"amplitude":0.24168,"preClose":63.1,"low":63.65,"week52Low":20.2,"pbRate":"47.25","week52High":78.9,"institutionHeld":0,"latestPrice":75.8,"committee":-0.75,"eps":-0.7871997137335578,"divideRate":0,"volume":2658720,"delay":0,"ttmEps":-1.1349883620721901,"open":65.15,"prevYearClose":13.15,"prevWeekClose":63.1,"prevMonthClose":54.15,"prevQuarterClose":30.15,"fiveDayClose":58,"twentyDayClose":43.04,"sixtyDayClose":13.15},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02617\",params:#limit:5,,,undefined,":[{"date":"2025-08-25","symbol":"02617","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756085400000,"name":null,"time":"","dateTimestamp":1756051200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02617\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02617\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02617\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02617","date":"2025-09-05","current":-57.867887,"percent":0.277778,"low":-72.789898,"twenty":-63.405379,"median":-50.300475,"eighty":-39.739866,"high":-17.403134,"avg":-50.543146,"sd":12.786891,"marketCap":25044240642},"quantilePoints":[{"date":"2025-06-20","current":-17.403134,"twenty":-17.403134,"median":-17.403134,"eighty":-17.403134,"marketCap":5219203873},{"date":"2025-06-27","current":-36.622688,"twenty":-34.709071,"median":-32.493198,"eighty":-31.066553,"marketCap":11013909315},{"date":"2025-07-04","current":-44.802949,"twenty":-38.622694,"median":-35.660049,"eighty":-31.776499,"marketCap":13474674640},{"date":"2025-07-11","current":-39.630155,"twenty":-40.38446,"median":-38.336544,"eighty":-32.816725,"marketCap":11906928990},{"date":"2025-07-18","current":-43.957869,"twenty":-42.111612,"median":-39.630155,"eighty":-34.373739,"marketCap":13196846297},{"date":"2025-07-25","current":-49.067594,"twenty":-42.195906,"median":-40.285196,"eighty":-36.230637,"marketCap":14784436829},{"date":"2025-08-01","current":-50.963195,"twenty":-45.655878,"median":-41.371359,"eighty":-36.620356,"marketCap":15260713988},{"date":"2025-08-08","current":-58.015216,"twenty":-51.234741,"median":-42.017389,"eighty":-37.993773,"marketCap":17415868136},{"date":"2025-08-15","current":-66.867935,"twenty":-57.065221,"median":-42.261724,"eighty":-38.707864,"marketCap":20043330466},{"date":"2025-08-22","current":-72.723484,"twenty":-59.09189,"median":-43.957869,"eighty":-39.464263,"marketCap":21730145406},{"date":"2025-08-29","current":-49.610789,"twenty":-64.458089,"median":-47.896219,"eighty":-39.630155,"marketCap":21492006826},{"date":"2025-09-05","current":-57.867887,"twenty":-63.405379,"median":-50.300475,"eighty":-39.739866,"marketCap":25044240642}],"updateTime":1757366325789},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02617\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1174923850","title":"HK Movers | Transthera-B, DualityBio-B Shares Surged About 16% After Being Added to the List of Securities for Southbound Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1174923850","media":"Tiger Newspress","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1174923850?lang=en_us&edition=fundamental","pubTime":"2025-09-08 10:51","pubTimestamp":1757299883,"startTime":"0","endTime":"0","summary":"Transthera-B, DualityBio-B shares surged about 16% after being added to the list of securities for Southbound Trading.","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09606","02617"],"gpt_icon":0},{"id":"1160465691","title":"TRANSTHERA-B Surges Nearly 11% in Early Trading to New Listing High as Company Joins Stock Connect","url":"https://stock-news.laohu8.com/highlight/detail?id=1160465691","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1160465691?lang=en_us&edition=fundamental","pubTime":"2025-09-08 10:20","pubTimestamp":1757298056,"startTime":"0","endTime":"0","summary":"TRANSTHERA-B (02617) jumped over 10% in early trading, reaching an intraday high of HK$78, setting a new record since its listing. As of press time, the stock was up 10.54% to HK$69.75, with a...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HSCEI","07226","HSTECH","YANG","BK1161","02617","BK4614"],"gpt_icon":1},{"id":"1153459765","title":"TRANSTHERA-B (02617): Phase II Clinical Trial of Tinengotinib Combined with AKESO's Kantani® (Cadonilimab, PD-1/CTLA-4) / Ivonesca® (Ivonescimab, PD-1/VEGF) Completes First Patient Dosing","url":"https://stock-news.laohu8.com/highlight/detail?id=1153459765","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1153459765?lang=en_us&edition=fundamental","pubTime":"2025-09-04 22:46","pubTimestamp":1756997181,"startTime":"0","endTime":"0","summary":"TRANSTHERA-B (02617) announced that the open-label, multi-center Phase II clinical studies of its core product Tinengotinib (TT-00420) in combination with AKESO Limited's Kantani® (Cadonilimab,...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0417516571.SGD","LU0561508036.HKD","BK1574","LU0348827113.USD","LU2488822045.USD","LU0417516738.SGD","LU1794554557.SGD","IE00B5MMRT66.SGD","IE00B543WZ88.USD","LU1720050803.USD","LU2778985437.USD","LU0348825331.USD","BK1161","PD","LU0634319403.HKD","LU0348783233.USD","LU0540923850.HKD","LU0417516902.SGD","LU2476274308.USD","LU0348767384.USD","LU0348735423.USD","LU0348766576.USD","LU1169589451.USD","IE00BPRC5H50.USD","02617","09926","BK4023","LU2476274720.SGD","LU0348784397.USD","LU1169590202.USD"],"gpt_icon":1},{"id":"2564038133","title":"TransThera Sciences Announces First Patient Dosed in Phase II Clinical Trial for Advanced Liver Cancer Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2564038133","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564038133?lang=en_us&edition=fundamental","pubTime":"2025-09-04 22:34","pubTimestamp":1756996463,"startTime":"0","endTime":"0","summary":"TransThera Sciences  Inc. has announced the initiation of a Phase II clinical trial involving their Core Product, Tinengotinib , in combination with Akeso, Inc.'s cadonilimab  and ivonescimab  for the treatment of advanced hepatocellular carcinoma . The trial is an open-label, multicenter study conducted in China, aimed at evaluating the safety and efficacy of these combination therapies in patients who have not previously received systemic anticancer therapy for HCC or have failed prior standard treatments. The announcement noted that this clinical study marks the first dosing of a patient, while results from the trial have not yet been presented.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Transthera Sciences  Inc. published the o","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250904:nNDL6Wxz7r:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BPRC5H50.USD","LU2488822045.USD","LU0540923850.HKD","LU0561508036.HKD","LU0417516902.SGD","LU2476274720.SGD","LU0348766576.USD","LU0417516738.SGD","LU0348767384.USD","LU0634319403.HKD","BK1574","LU0348735423.USD","LU0348827113.USD","LU0348825331.USD","IE00B543WZ88.USD","LU2778985437.USD","BK1161","LU1720050803.USD","LU0417516571.SGD","LU2476274308.USD","LU0348783233.USD","LU0348784397.USD","02617","IE00B5MMRT66.SGD","LU1794554557.SGD"],"gpt_icon":1}],"pageSize":4,"totalPage":5,"pageCount":1,"totalSize":18,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/02617\",params:#limit:6,delay:false,,,undefined,":[]}}